Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bray

Showing results (241-250 of 247) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 247 results.
Clinical Chemistry|October 3, 1999
Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigenD W Chan, C A Kelley, T L Ratliff, et al.
Clinical Biochemistry|September 8, 2014
Diagnostic performance of cardiac Troponin I for early rule-in and rule-out of acute myocardial infarction: Results of a prospective multicenter trialAlan B Storrow, Robert H Christenson, Richard M Nowak, et al.
Gastroenterology|November 13, 2019
Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of ProteinsGeert D'Haens, Orlaith Kelly, Robert Battat, et al.
BMJ Open|August 17, 2025
Co-development of a Post-Acute Care Intervention for Frailty using Information and Communication technology (PACIFIC): a development process protocolLauren E Griffith, Luciana Macedo, Cynthia Lokker, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Spyglass: a framework for reproducible and shareable neuroscience researchKyu Hyun Lee, Eric L Denovellis, Ryan Ly, et al.
Hepatology (Baltimore, Md.)|March 18, 2022
Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunityCerise Yuen-Ki Chan, Vincent Wai-Hin Yuen, David Kung-Chun Chiu, et al.
Journal of Medicinal Chemistry|March 13, 2015
The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer AgentsYong Liu, Yunhui Lang, Narendra Kumar Patel, et al.
Pageof 25

Showing results (241-250 of 247) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 247 results.
Clinical Chemistry|October 3, 1999
Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigenD W Chan, C A Kelley, T L Ratliff, et al.
Clinical Biochemistry|September 8, 2014
Diagnostic performance of cardiac Troponin I for early rule-in and rule-out of acute myocardial infarction: Results of a prospective multicenter trialAlan B Storrow, Robert H Christenson, Richard M Nowak, et al.
Gastroenterology|November 13, 2019
Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of ProteinsGeert D'Haens, Orlaith Kelly, Robert Battat, et al.
BMJ Open|August 17, 2025
Co-development of a Post-Acute Care Intervention for Frailty using Information and Communication technology (PACIFIC): a development process protocolLauren E Griffith, Luciana Macedo, Cynthia Lokker, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Spyglass: a framework for reproducible and shareable neuroscience researchKyu Hyun Lee, Eric L Denovellis, Ryan Ly, et al.
Hepatology (Baltimore, Md.)|March 18, 2022
Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunityCerise Yuen-Ki Chan, Vincent Wai-Hin Yuen, David Kung-Chun Chiu, et al.
Journal of Medicinal Chemistry|March 13, 2015
The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer AgentsYong Liu, Yunhui Lang, Narendra Kumar Patel, et al.
Pageof 25